Updating Data on Cognitive Impairment in Stroke Patients
Abstract
:Introduction
Discussions
Etiological and risk factors of cognitive decline after stroke
Neuropsychological and behavioral changes
Clinical forms of vascular dementia
Vascular subcortical dementia
Vascular cortical dementia or multi-infarct dementia
Dementia caused by specific localized infarcts
Dementia from CADASIL
Dementia from cerebral amyloid angiopathy (CAA)
Dementia caused by subcortical white matter lesions
Paraclinical methods
Electroencephalography (EEG)
Computerized cranial tomography (CT)
Magnetic resonance imaging (MRI)
New magnetic resonance and molecular imaging techniques
Single photon emission computed tomography (SPECT)
Positron emission computed tomography
Principles of treatment in vascular dementia
Preventive treatment in vascular dementia
Current treatment of vascular dementia
- ○
- Antithrombotic therapy
- ○
- Ergot alkaloids
- ○
- Xanthine derivatives
- ○
- Calcium antagonists
- ○
- NMDA receptor antagonists
- ○
- Ginkgo biloba extract
- ○
- Serotonergic receptor antagonists
- ○
- Cholinesterase inhibitors
Conclusions
Funding
Informed Consent Statement
Conflicts of Interest
References
- Cummings, J. Dementia: the failing brain. Lancet 1995, 345, 1481–1484. [Google Scholar] [CrossRef]
- Davis, H.S.; Rockwood, K. Conceptualization of mild cognitive impairment: a review. Int. J. Geriatr. Psychiatry 2004, 19, 313–319. [Google Scholar] [CrossRef]
- Chui, H.C.; Mack, W.; Jackson, J.E.; Mungas, D.; Reed, B.R.; Tinklenberg, J.; Chang, F.-L.; Skinner, K.; Tasaki, C.; Jagust, W.J. Clinical Criteria for the Diagnosis of Vascular Dementia: a multicenter study of compara-bility and interrater reliability. Arch. Neurol. 2000, 57, 191–196. [Google Scholar] [CrossRef]
- del Ser, T.; Bermejo, F.; Portera, A.; Arredondo, J.; Bouras, C.; Constantinidis, J. Vascular dementia: A clinicopathological study. J. Neurol. Sci. 1990, 96, 1–17. [Google Scholar] [CrossRef]
- Agüero-Torres, H.; Kivipelto, M.; von Strauss, E. Rethinking the Dementia Diagnoses in a Population-Based Study: What Is Alzheimer’s Disease and What Is Vascular Dementia? A study from the kungsholmen project. Dement. Geriatr. Cogn. Disord. 2006, 22, 244–249. [Google Scholar] [CrossRef]
- Rost, N.S.; Brodtmann, A.; Pase, M.P.; van Veluw, S.J.; Biffi, A.; Duering, M.; Hinman, J.D.; Dichgans, M. Post-Stroke Cognitive Impairment and Dementia. Circ. Res. 2022, 130, 1252–1271. [Google Scholar] [CrossRef]
- Chui, H.; Gonthier, R. Natural history of vascular dementia. Alzheimer Dis Assoc Disord. 1999, 13 (Suppl. 3), S124–S130. [Google Scholar]
- Aharon-Peretz, J.; Cummings, J.L.; Hill, M.A. Vascular Dementia and Dementia of the Alzheimer Type. Cognition, ventricular size, and leuko-araiosis. Arch. Neurol. 1988, 45, 719–721. [Google Scholar] [CrossRef]
- Almkvist, O.; Bäckman, L.; Basun, H.; Wahlund, L.-O. Patterns of Neuropsychological Performance in Alzheimer's Disease and Vascular Dementia. Cortex 1993, 29, 661–673. [Google Scholar] [CrossRef]
- Eiser, A.R. Mild Cognitive Impairment and the Missed Opportunity to Prevent Dementia. Am. J. Med. 2024, 137, 689–691. [Google Scholar] [CrossRef]
- Pan, A.P.; Potter, T.; Bako, A.; Tannous, J.; Seshadri, S.; McCullough, L.D.; Vahidy, F.S. Lifelong cerebrovascular disease burden among CADASIL patients: analysis from a global health research network. Front. Neurol. 2023, 14, 1203985. [Google Scholar] [CrossRef] [PubMed]
- Barba, R.; Martínez-Espinosa, S.; Rodríguez-García, E.; Pondal, M.; Vivancos, J.; Del Ser, T. Poststroke Dementia : clinical features and risk factors. Stroke 2000, 31, 1494–1501. [Google Scholar] [CrossRef] [PubMed]
- Manini, A.; Pantoni, L. CADASIL from Bench to Bedside: Disease Models and Novel Therapeutic Approaches. Mol. Neurobiol. 2021, 58, 2558–2573. [Google Scholar] [CrossRef] [PubMed]
- Choudhary, S.; McLeod, M.; Torchia, D.; Romanelli, P. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL). J Clin Aesthet Dermatol. 2013, 6, 29–33. [Google Scholar]
- Caronti, B.; Calandriello, L.; Francia, A.; Scorretti, L.; Manfredi, M.; Sansolini, T.; Pennisi, E.M.; Calderaro, C.; Palladini, G. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leuco-encephalopathy (CADASIL). Neuropathological and in vitro studies of abnormal elastogenesis. Acta Neurol. Scand. 1998, 98, 259–267. [Google Scholar] [CrossRef]
- Vinters, H.V.; Ellis, W.G.; Zarow, C.; Zaias, B.W.; Jagust, W.J.; Mack, W.J.; Chui, H.C. Neuropathologic Substrates of Ischemic Vascular Dementia. J. Neuropathol. Exp. Neurol. 2000, 59, 931–945. [Google Scholar] [CrossRef]
- Vinters, H.V.; Gilbert, J.J. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 1983, 14, 924–928. [Google Scholar] [CrossRef]
- Opeskin, K. Cerebral Amyloid Angiopathy. A review. Am. J. Forensic Med. Pathol. 1996, 17, 248–254. [Google Scholar] [CrossRef]
- Moroney, J.; Bagiella, E.; Desmond, D.; Paik, M.; Stern, Y.; Tatemichi, T. Risk Factors for Incident Dementia After Stroke. Role of hypoxic and ischemic dis-orders. Stroke 1996, 27, 1283–1289. [Google Scholar] [CrossRef]
- Meyer, J.S.; Rauch, G.; A Rauch, R.; Haque, A. Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia. Neurobiol. Aging 2000, 21, 161–169. [Google Scholar] [CrossRef]
- Skoog, I.; Kalaria, R.N.; Breteler, M.M.B. Vascular Factors and Alzheimer Disease. Alzheimer Dis. Assoc. Disord. 1999, 13 (Suppl. 3), S106–S114. [Google Scholar] [CrossRef]
- Briley, D.P.; Haroon, S.; Sergent, S.M.; Thomas, S. Does leukoaraiosis predict morbidity and mortality? Neurology 2000, 54, 90–90. [Google Scholar] [CrossRef] [PubMed]
- Brun, A.; Englund, E. A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study. Ann. Neurol. 1986, 19, 253–262. [Google Scholar] [CrossRef] [PubMed]
- Goldberg, M.P.; Ransom, B.R. New Light on White Matter. Stroke 2003, 34, 330–332. [Google Scholar] [CrossRef] [PubMed]
- Olsen, C.G.; Clasen, M.E. Senile dementia of the Binswanger's type. Am Fam Physician. 1998, 58, 2068–2074. [Google Scholar]
- Munoz, D.G. The Pathological Basis of Multi-Infarct Dementia. Alzheimer Dis. Assoc. Disord. 1991, 5, 77–90. [Google Scholar] [CrossRef]
- Leys, D.; Hénon, H.; Pasquier, F. White Matter Changes and Poststroke Dementia. Dement. Geriatr. Cogn. Disord. 1998, 9 (Suppl.1), 25–29. [Google Scholar] [CrossRef]
- Kirkpatrick, J.B.; A Hayman, L. White-matter lesions in MR imaging of clinically healthy brains of elderly subjects: possible pathologic basis. Radiology 1987, 162, 509–511. [Google Scholar] [CrossRef]
- Merino, J.G.; Hachinski, V. Leukoaraiosis: reifying rarefaction. Arch. Neurol. 2000, 57, 925–6. [Google Scholar] [CrossRef]
- Mento, C.; Lombardo, C.; Whithorn, N.; Muscatello, M.R.A.; Bruno, A.; Casablanca, M.; Silvestri, M.C. Psychological violence and manipulative behavior in couple: A focus on personality traits. J. Mind Med Sci. 2023, 10, 172–177. [Google Scholar] [CrossRef]
- Hassan, A.; Hunt, B.J.; O’sullivan, M.; Parmar, K.; Bamford, J.M.; Briley, D.; Brown, M.M.; Thomas, D.J.; Markus, H.S. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003, 126 (Pt. 2), 424–432. [Google Scholar] [CrossRef]
- van Zagten, M.; Boiten, J.; Kessels, F.; Lodder, J. Significant Progression of White Matter Lesions and Small Deep (Lacunar) Infarcts in Patients With Stroke. Arch. Neurol. 1996, 53, 650–655. [Google Scholar] [CrossRef] [PubMed]
- Brun, A.; Englund, E. Neuropathological Brain Mapping. Dement. Geriatr. Cogn. Disord. 1997, 8, 123–127. [Google Scholar] [CrossRef]
- Coupland, K.; Lendahl, U.; Karlström, H. Role of NOTCH3 Mutations in the Cerebral Small Vessel Disease Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy. Stroke 2018, 49, 2793–2800. [Google Scholar] [CrossRef] [PubMed]
- Cummings, J.L. Multi-infarct dementia: Diagnosis and management: Infarctions produce 20% to 35% of severe dementia cases. Psychosomatics 1987, 28, 117–126. [Google Scholar] [CrossRef]
- Miyao, S.; Takano, A.; Teramoto, J.; Takahashi, A. Leukoaraiosis in relation to prognosis for patients with lacunar infarction. Stroke 1992, 23, 1434–1438. [Google Scholar] [CrossRef]
- Liu, C.K.; Miller, B.L.; Cummings, J.L.; Mehringer, C.M.; Goldberg, M.A.; Howng, S.L.; Benson, D.F. A quantitative MRI study of vascular dementia. Neurology 1992, 42, 138–138. [Google Scholar] [CrossRef]
- Knopman, D.S.; DeKosky, S.T.; Cummings, J.L.; Chui, H.; Corey–Bloom, J.; Relkin, N.; Small, G.W.; Miller, B.; Stevens, J.C. Practice parameter: Diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001, 56, 1143–1153. [Google Scholar] [CrossRef]
- Tatemichi, T.K.; Desmond, D.W.; Stern, Y.; Paik, M.; Sano, M.; Bagiella, E. Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities. J. Neurol. Neurosurg. Psychiatry 1994, 57, 202–207. [Google Scholar] [CrossRef]
- van Zandvoort, M.; A. A, A.; Kappelle, L.; De Haan, E. Cognitive Functioning before and after a Lacunar Infarct. Cerebrovasc. Dis. 2000, 10, 478–479. [Google Scholar] [CrossRef]
- Pohjasvaara, T.; Mäntylä, R.; Salonen, O.; Aronen, H.; Ylikoski, R.; Hietanen, M.; Kaste, M.; Erkinjuntti, T. MRI correlates of dementia after first clinical ischemic stroke. J. Neurol. Sci. 2000, 181, 111–117. [Google Scholar] [CrossRef]
- Mateescu, M.-C.; Grigorescu, S.; Socea, B.; Bloanca, V.; Grigorescu, O.-D. Contribution to the Personalized Management of the Nosocomial Infections: A New Paradigm Regarding the Influence of the Community Microbial Environment on the Incidence of the Healthcare-Associated Infections (HAI) in Emergency Hospital Surgical Departments. J. Pers. Med. 2023, 13, 210. [Google Scholar] [CrossRef]
- Wallin, A.; Blennow, K. Pathogenetic Basis of Vascular Dementia. Alzheimer Dis. Assoc. Disord. 1991, 5, 91–102. [Google Scholar] [CrossRef]
- Berg, A.; Palomäki, H.; Lehtihalmes, M.; Lönnqvist, J.; Kaste, M. Poststroke Depression: an 18-month follow-up. Stroke 2003, 34, 138–143. [Google Scholar] [CrossRef]
- Parrotta, I.; Cacciatore, S.; D’andrea, F.; D’anna, M.; Giancaterino, G.; Lazzaro, G.; Arcara, G.; Manzo, N. Prevalence, treatment, and neural correlates of apathy in different forms of dementia: a narrative review. Neurol. Sci. 2023, 45, 1343–1376. [Google Scholar] [CrossRef]
- MacHale, S.M.; O’rourke, S.J.; Wardlaw, J.M.; Dennis, M.S. Depression and its relation to lesion location after stroke. J. Neurol. Neurosurg. Psychiatry 1998, 64, 371–374. [Google Scholar] [CrossRef]
- Albu, V.C.; Sandu, R.E.; Barbulescu, A.L.; Tartea, E.-A.; Burada, E.; Taisescu, O.; Vreju, F.A.; Boldeanu, M.V.; Boldeanu, L.; Enescu, A.; et al. The Relationship between the Acute Confusing State and the Comorbidities of the Elderly Patient. Rev. de Chim. 2019, 70, 2415–2419. [Google Scholar] [CrossRef]
- House, A.; Dennis, M.; Mogridge, L.; Warlow, C.; Hawton, K.; Jones, L. Mood Disorders in the Year after First Stroke. Br. J. Psychiatry 1991, 158, 83–92. [Google Scholar] [CrossRef]
- House, A.; Dennis, M.; Warlow, C.; Hawton, K.; Molyneux, A. The relationship between intellectual impairment and mood disorder in the first year after stroke. Psychol. Med. 1990, 20, 805–814. [Google Scholar] [CrossRef]
- Pohjasvaara, T.; Leppävuori, A.; Siira, I.; Vataja, R.; Kaste, M.; Erkinjuntti, T. Frequency and Clinical Determinants of Poststroke Depression. Stroke 1998, 29, 2311–2317. [Google Scholar] [CrossRef]
- Hackett, M.L.; Yapa, C.; Parag, V.; Anderson, C.S. Frequency of Depression After Stroke: a systematic review of observational studies. Stroke 2005, 36, 1330–1340. [Google Scholar] [CrossRef]
- Adnan, S.; Shah, M.; Rashed, M.F.; Nawab, S. Prevalent distribution of conscious processes on either side of the brain. J. Mind Med Sci. 2023, 10, 295–303. [Google Scholar] [CrossRef]
- Gabaldón, L.; Fuentes, B.; Frank-García, A.; Díez-Tejedor, E. Poststroke Depression: Importance of Its Detection and Treatment. Cerebrovasc. Dis. 2007, 24, 181–188. [Google Scholar] [CrossRef]
- Purandare, N.; Allen; Burns, A. Behavioural and psychological symptoms of dementia. Rev. Clin. Gerontol. 2000, 10, 245–260. [Google Scholar] [CrossRef]
- Rao, S.M.; Mittenberg, W.; Bernardin, L.; Haughton, V.; Leo, G.J. Neuropsychological Test Findings in Subjects With Leukoaraiosis. Arch. Neurol. 1989, 46, 40–44. [Google Scholar] [CrossRef]
- Socea, B.; Silaghi, A.; Rebegea, L.F.; Balan, D.G.; Balalau, C.; Tenea-Cojan, T.Ș.; Mihai, D.A.; Paunica, I. Diabetes mellitus: interdisciplinary medical, surgical and psychological therapeutic approach. J. Mind Med Sci. 2023, 10, 217–236. [Google Scholar] [CrossRef]
- Huisa, B.N.; A Rosenberg, G. Binswanger’s disease: toward a diagnosis agreement and therapeutic approach. Expert Rev. Neurother. 2014, 14, 1203–1213. [Google Scholar] [CrossRef]
- Hurley, R.A.; Tomimoto, H.; Akiguchi, I.; Fisher, R.E.; Taber, K.H. Binswanger's Disease: An Ongoing Controversy. J. Neuropsychiatry Clin Neurosci. 2000, 12, 301–304. [Google Scholar] [CrossRef]
- Kalaria, R.N. The pathology and pathophysiology of vascular dementia. Neuropharmacology 2018, 134(Pt. B), 226–239. [Google Scholar] [CrossRef]
- Román, G.C.; Erkinjuntti, T.; Wallin, A.; Pantoni, L.; Chui, H.C. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002, 1, 426–436. [Google Scholar] [CrossRef]
- Tomimoto, H. Subcortical vascular dementia. Neurosci. Res. 2011, 71, 193–199. [Google Scholar] [CrossRef]
- Zhao, L.; Biesbroek, J.M.; Shi, L.; Liu, W.; Kuijf, H.J.; Chu, W.W.; Abrigo, J.M.; Lee, R.K.; Leung, T.W.; Lau, A.Y.; et al. Strategic infarct location for post-stroke cognitive impairment: A multivariate lesion-symptom mapping study. J. Cereb. Blood Flow Metab. 2017, 38, 1299–1311. [Google Scholar] [CrossRef]
- Biesbroek, J.M.; Weaver, N.A.; Biessels, G.J. Lesion location and cognitive impact of cerebral small vessel disease. Clin. Sci. 2017, 131, 715–728. [Google Scholar] [CrossRef]
- Bates, E.; Wilson, S.M.; Saygin, A.P.; Dick, F.; Sereno, M.I.; Knight, R.T.; Dronkers, N.F. Voxel-based lesion–symptom mapping. Nat. Neurosci. 2003, 6, 448–450. [Google Scholar] [CrossRef]
- Buffon, F.; Porcher, R.; Hernandez, K.; Kurtz, A.; Pointeau, S.; Vahedi, K.; Bousser, M.-G.; Chabriat, H. Cognitive profile in CADASIL. J. Neurol. Neurosurg. Psychiatry 2006, 77, 175–180. [Google Scholar] [CrossRef]
- Amberla, K.; Wäljas, M.; Tuominen, S.; Almkvist, O.; Pöyhönen, M.; Tuisku, S.; Kalimo, H.; Viitanen, M.; C, C.; J, C.; et al. Insidious Cognitive Decline in CADASIL. Stroke 2004, 35, 1598–1602. [Google Scholar] [CrossRef]
- Jolly, A.A.; Nannoni, S.; Edwards, H.; Morris, R.G.; Markus, H.S. Prevalence and Predictors of Vascular Cognitive Impairment in Patients With CADASIL. Neurology 2022, 99, e453–e461. [Google Scholar] [CrossRef]
- Ghiso, J.; Frangione, B. Cerebral amyloidosis, amyloid angiopathy, and their relationship to stroke and dementia. J. Alzheimer's Dis. 2001, 3, 65–73. [Google Scholar] [CrossRef]
- Greenberg, S.M.; Bacskai, B.J.; Hernandez-Guillamon, M.; Pruzin, J.; Sperling, R.; van Veluw, S.J. Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways. Nat Rev Neurol. 2020, 16, 30–42. [Google Scholar] [CrossRef]
- Jäkel, L.; De Kort, A.M.; Klijn, C.J.; Schreuder, F.H.; Verbeek, M.M. Prevalence of cerebral amyloid angiopathy: A systematic review and meta-analysis. Alzheimer's Dement. 2021, 18, 10–28. [Google Scholar] [CrossRef]
- Stoian, A.; Hainarosie, R.; Pietrosanu, C.; Rusescu, A.; Andronache, L.; Paunica, S.; Balalau, C.; Pituru, T. Modern concepts in non-surgical esthetics; a review. J. Mind Med Sci. 2019, 6, 190–195. [Google Scholar] [CrossRef]
- Erkinjuntti, T.; Larsen, T.; Sulkava, R.; Ketonen, L.; Laaksonen, R.; Palo, J. EEG in the differential diagnosis between Alzheimer's disease and vascular dementia. Acta Neurol. Scand. 1988, 77, 36–43. [Google Scholar] [CrossRef]
- Jordan, K.G. Emergency EEG and continuous EEG monitoring in acute ischemic stroke. J Clin Neurophysiol. 2004, 21, 341–52. [Google Scholar]
- Finnigan, S.; van Putten, M.J. EEG in ischaemic stroke: Quantitative EEG can uniquely inform (sub-)acute prognoses and clinical management. Clin. Neurophysiol. 2012, 124, 10–19. [Google Scholar] [CrossRef]
- Adamis, D.; Sahu, S.; Treloar, A. The utility of EEG in dementia: a clinical perspective. Int. J. Geriatr. Psychiatry 2005, 20, 1038–1045. [Google Scholar] [CrossRef]
- Finnigan, S.P.; Walsh, M.; Rose, S.E.; Chalk, J.B. Quantitative EEG indices of sub-acute ischaemic stroke correlate with clinical outcomes. Clin. Neurophysiol. 2007, 118, 2525–2532. [Google Scholar] [CrossRef]
- Neto, E.; Allen, E.A.; Aurlien, H.; Nordby, H.; Eichele, T. EEG Spectral Features Discriminate between Alzheimer’s and Vascular Dementia. Front. Neurol. 2015, 6, 25–25. [Google Scholar] [CrossRef]
- Frisoni, G.B.; Beltramello, A.; Binetti, G.; Bianchetti, A.; Weiss, C.; Scuratti, A.; Trabucchi, M. Computed Tomography in the Detection of the Vascular Component in Dementia. Gerontology 1995, 41, 121–128. [Google Scholar] [CrossRef]
- Yang, X.; Chen, C.; Wang, A.; Li, C.; Cheng, G. Imaging, Genetic, and Pathological Features of Vascular Dementia. Eur. Neurol. 2023, 86, 277–284. [Google Scholar] [CrossRef]
- Meyer, J.S.; Muramatsu, K.; Mortel, K.F.; Obara, K.; Shirai, T. Prospective CT Confirms Differences Between Vascular and Alzheimer’s Dementia. Stroke 1995, 26, 735–742. [Google Scholar] [CrossRef]
- Engel, P.A.; Gelber, J. Does Computed Tomographic Brain Imaging Have a Place in the Diagnosis of Dementia? Arch. Intern. Med. 1992, 152, 1437–1440. [Google Scholar] [CrossRef]
- Wollman, D.E.; Prohovnik, I. Sensitivity and specificity of neuroimaging for the diagnosis of Alzheimer's disease. Dialogues Clin Neurosci. 2003, 5, 89–99. [Google Scholar] [CrossRef]
- Henneman, W.J.; Sluimer, J.D.; Barnes, J.; et al. Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures. Neurology 2009, 72, 999–1007. [Google Scholar] [CrossRef]
- Raji, C.A.; Benzinger, T.L.S. The Value of Neuroimaging in Dementia Diagnosis. Contin. Lifelong Learn. Neurol. 2022, 28, 800–821. [Google Scholar] [CrossRef]
- Mangesius, S.; Janjic, T.; Steiger, R.; Haider, L.; Rehwald, R.; Knoflach, M.; Widmann, G.; Gizewski, E.; Grams, A. Dual-energy computed tomography in acute ischemic stroke: state-of-the-art. Eur. Radiol. 2020, 31, 4138–4147. [Google Scholar] [CrossRef]
- Román, G.C. New insight into Binswanger disease. Arch. Neurol. 1999, 56, 1061–1062. [Google Scholar] [CrossRef]
- Pitkänen, J.; Koikkalainen, J.; Nieminen, T.; Marinkovic, I.; Curtze, S.; Sibolt, G.; Jokinen, H.; Rueckert, D.; Barkhof, F.; Schmidt, R.; et al. Evaluating severity of white matter lesions from computed tomography images with convolutional neural network. Neuroradiology 2020, 62, 1257–1263. [Google Scholar] [CrossRef]
- Inzitari, D. Leukoaraiosis: an independent risk factor for stroke? Stroke 2003, 34, 2067–2071. [Google Scholar] [CrossRef]
- Gorelick, P.B.; Chatterjee, A.; Patel, D.; Flowerdew, G.; Dollear, W.; Taber, J.; Harris, Y. Cranial computed tomographic observations in multi-infarct dementia. A controlled study. Stroke 1992, 23, 804–811. [Google Scholar] [CrossRef]
- Razek, A.A.K.A.; Elsebaie, N.A. Imaging of vascular cognitive impairment. Clin. Imaging 2021, 74, 45–54. [Google Scholar] [CrossRef]
- Kertesz, A.; Polk, M.; Carr, T. Cognition and White Matter Changes on Magnetic Resonance Imaging in Dementia. Arch. Neurol. 1990, 47, 387–391. [Google Scholar] [CrossRef] [PubMed]
- Živanović, M.; Trenkić, A.A.; Milošević, V.; Stojanov, D.; Mišić, M.; Radovanović, M.; Radovanović, V. The role of magnetic resonance imaging in the diagnosis and prognosis of dementia. Bosn. J. Basic Med Sci. 2022, 23, 209–224. [Google Scholar] [CrossRef] [PubMed]
- Kaya, D.; Dinçer, A.; Yildiz, M.; Çizmeli, M.; Erzen, C. Acute Ischemic Infarction Defined by a Region of Multiple Hypointense Vessels on Gradient-Echo T2* MR Imaging at 3T. Am. J. Neuroradiol. 2009, 30, 1227–1232. [Google Scholar] [CrossRef]
- Zhou, W.; Li, L.; Lang, Y.; Jiang, H. Clinical characteristics of cerebral vascular dementia and early diagnostic value of cranial nuclear magnetic resonance. Pak. J. Med Sci. 2023, 39, 508–512. [Google Scholar] [CrossRef]
- Xiong, Y.Y.; Mok, V. Age-Related White Matter Changes. J. Aging Res. 2011, 2011, 7927. [Google Scholar] [CrossRef]
- Neumann-Haefelin, T.; Wittsack, H.-J.; Wenserski, F.; Siebler, M.; Seitz, R.J.; Mödder, U.; Freund, H.-J. Diffusion- and Perfusion-Weighted MRI. The DWI/PWI mismatch region in acute Stroke. Stroke 1999, 30, 1591–1597. [Google Scholar] [CrossRef]
- Motofei, I.G. A dual physiological character for cerebral mechanisms of sexuality and cognition: common somatic peripheral afferents. BJU Int. 2011, 108, 1634–1639. [Google Scholar] [CrossRef]
- Wang, T.; Mantini, D.; Gillebert, C.R. The potential of real-time fMRI neurofeedback for stroke rehabilitation: A systematic review. Cortex 2018, 107, 148–165. [Google Scholar] [CrossRef]
- Edlow, B.L.; Hurwitz, S.; Edlow, J.A. Diagnosis of DWI-negative acute ischemic stroke: A meta-analysis. Neurology 2017, 89, 256–262. [Google Scholar] [CrossRef]
- Roberts, T.P.; Rowley, H.A. Diffusion weighted magnetic resonance imaging in stroke. Eur. J. Radiol. 2003, 45, 185–194. [Google Scholar] [CrossRef]
- Badea, A.; Johnson, G.A. Magnetic resonance microscopy. Anal Cell Pathol (Amst) 2012, 35, 205–227. [Google Scholar] [CrossRef] [PubMed]
- Masdeu, J.C.; Brass, L.M. SPECT Imaging of Stroke. J. Neuroimaging 1995, 5, s14–s22. [Google Scholar] [CrossRef] [PubMed]
- Szigeti, K.; Horváth, I.; Veres, D.S.; Martinecz, B.; Lénárt, N.; Kovács, N.; Bakcsa, E.; Márta, A.; Semjéni, M.; Máthé, D.; et al. A Novel SPECT-Based Approach Reveals Early Mechanisms of Central and Peripheral Inflammation after Cerebral Ischemia. J. Cereb. Blood Flow Metab. 2015, 35, 1921–1929. [Google Scholar] [CrossRef] [PubMed]
- Alexandrov, A.V.; Black, S.E.; Ehrlich, L.E.; Bladin, C.F.; Smurawska, L.T.; Pirisi, A.; Caldwell, C.B. Simple Visual Analysis of Brain Perfusion on HMPAO SPECT Predicts Early Outcome in Acute Stroke. Stroke 1996, 27, 1537–1542. [Google Scholar] [CrossRef]
- Muehllehner, G.; Karp, J.S. Positron emission tomography. Phys. Med. Biol. 2006, 51, R117–R137. [Google Scholar] [CrossRef]
- Tai, Y.F.; Piccini, P. Applications of positron emission tomography (PET) in neurology. J. Neurol. Neurosurg. Psychiatry 2004, 75, 669–676. [Google Scholar] [CrossRef]
- Ferris, S.H.; de Leon, M.J.; Wolf, A.P.; Farkas, T.; Christman, D.R.; Reisberg, B.; Fowler, J.S.; MacGregor, R.; Goldman, A.; George, A.E.; et al. Positron Emission Tomography in the Study of Aging and Senile Dementia. Neurobiol. Aging 1980, 1, 127–131. [Google Scholar] [CrossRef]
- De Reuck, J.; Decoo, D.; Marchau, M.; Santens, P.; Lemahieu, I.; Strijckmans, K. Positron emission tomography in vascular dementia. J. Neurol. Sci. 1998, 154, 55–61. [Google Scholar] [CrossRef]
- Shyu, W.-C.; Lin, J.-C.; Shen, C.-C.; Hsu, Y.-D.; Lee, C.-C.; Shiah, I.-S.; Tsao, W.-L. Vascular dementia of Binswanger's type: clinical, neuroradiological and99mTc-HMPAO SPET study. Eur. J. Nucl. Med. 1996, 23, 1338–1344. [Google Scholar] [CrossRef]
- Meguro, K.; Doi, C.; Ueda, M.; Yamaguchi, T.; Matsui, H.; Kinomura, S.; Itoh, M.; Yamada, K.; Sasaki, H. Decreased cerebral glucose metabolism associated with mental deterioration in multi-infarct dementia. Neuroradiology 1991, 33, 305–309. [Google Scholar] [CrossRef]
- Román, G.C. Vascular Dementia Prevention: A Risk Factor Analysis. Cerebrovasc. Dis. 2005, 20 (Suppl. 2), 91–100. [Google Scholar] [CrossRef] [PubMed]
- McVeigh, C.; Passmore, P. Vascular dementia: prevention and treatment. Clin. Interv. Aging 2006, 1, 229–235. [Google Scholar] [CrossRef]
- Tzourio, C.; Anderson, C. PROGRESS Management Committee Blood pressure reduction and risk of dementia in patients with stroke: rationale of the dementia assessment in PROGRESS (Perindopril Protection Against Recurrent Stroke Study). PROGRESS Management Committee. J Hypertens Suppl. 2000, 18, S21–S24. [Google Scholar] [PubMed]
- Folstein, M.F.; Folstein, S.E.; McHugh, P.R. “Mini-Mental State”. A Practical Method for Grading the Cognitive State of Patients for the Clinician. J. Psychiatr. Res. 1975, 12, 189–198. [Google Scholar] [CrossRef]
- Appleton, J.P.; Scutt, P.; Sprigg, N.; Bath, P.M. Hypercholesterolaemia and vascular dementia. Clin. Sci. 2017, 131, 1561–1578. [Google Scholar] [CrossRef]
- Dart, A.M.; Chin-Dusting, J.P. Lipids and the endothelium. Cardiovasc. Res. 1999, 43, 308–322. [Google Scholar] [CrossRef]
- Greco, A.; Occhipinti, G.; Giacoppo, D.; Agnello, F.; Laudani, C.; Spagnolo, M.; Mauro, M.S.; Rochira, C.; Finocchiaro, S.; Mazzone, P.M.; et al. Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke: JACC State-of-the-Art Review. J Am Coll cardiol. 2023, 82, 1538–1557. [Google Scholar] [CrossRef]
- Bumbea, A.M.; Trăistaru, M.R.; Dinescu, S.-C.; Bumbea, B.Ş.; Albulescu, D.M.; Niculescu, M.; Krastev, B.M.; Muşetescu, A.E. Cervical adenocarcinoma generator of procoagulant status and ischemic stroke. Rom. J. Morphol.Embryol. 2017, 58, 1477–1484. [Google Scholar]
- Meyer, J.S.; Rogers, R.L.; McClintic, K.; Mortel, K.F.; Lotfi, J. Randomized Clinical Trial of Daily Aspirin Therapy in Multi-Infarct Dementia. J. Am. Geriatr. Soc. 1989, 37, 549–555. [Google Scholar] [CrossRef]
- Ikonomidis, I.; Andreotti, F.; Economou, E.; Stefanadis, C.; Toutouzas, P.; Nihoyannopoulos, P. Increased Proinflammatory Cytokines in Patients With Chronic Stable Angina and Their Reduction By Aspirin. Circulation 1999, 100, 793–798. [Google Scholar] [CrossRef]
- He, D.; Guo, Y.; Zhang, Y.; Zhao, J.; Wu, L.; Yu, Z.; Qu, W.; Luo, X. Thromboelastography predicts dual antiplatelet therapy-related hemorrhage in patients with acute ischemic stroke. J. NeuroInterventional Surg. 2021, 14, 672–676. [Google Scholar] [CrossRef] [PubMed]
- Marginean, C.M.; Pirscoveanu, D.; Popescu, M.; Vasile, C.M.; Docea, A.O.; Mitruț, R.; Mărginean, I.C.; Iacob, G.A.; Firu, D.M.; Mitruț, P. Challenges in Diagnosis and Therapeutic Approach of Acute on Chronic Liver Failure—A Review of Current Evidence. Biomedicines 2023, 11, 1840. [Google Scholar] [CrossRef]
- Mukherjee, J.; Menge, M. Progress and Prospects of Ergot Alkaloid Research. In New Products and New Areas of Bioprocess Engineering; Springer: Berlin/Heidelberg, Germany, 2000; Volume 68. [Google Scholar] [CrossRef]
- Elwan, O.; Helmy, A.; Tamawy, M.; Naseer, M.; Banhawy, I.; Kader, A.; Elwan, F. Ergoloids and Ischaemic Strokes; Efficacy and Mechanism of Action. J. Int. Med Res. 1995, 23, 154–166. [Google Scholar] [CrossRef]
- Schneider, L.S.; Olin, J.T. Overview of Clinical Trials of Hydergine in Dementia. Arch. Neurol. 1994, 51, 787–798. [Google Scholar] [CrossRef]
- Sortino, M.A.; Battaglia, A.; Pamparana, F.; Carfagna, N.; Post, C.; Canonico, P.L. Neuroprotective effects of nicergoline in immortalized neurons. Eur. J. Pharmacol. 1999, 368, 285–290. [Google Scholar] [CrossRef]
- Im, J.J.; Jeong, H.S.; Park, J.-S.; Yang, Y.; Na, S.-H.; Oh, J.K.; Chung, Y.-A.; Song, I.-U. Changes in Regional Cerebral Perfusion after Nicergoline Treatment in Early Alzheimer's Disease: A Pilot Study. Dement. Neurocognitive Disord. 2017, 16, 104–109. [Google Scholar] [CrossRef]
- Meskini, N.; Némoz, G.; Okyayuz-Baklouti, I.; Lagarde, M.; Prigent, A.-F. Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation. Biochem. Pharmacol. 1994, 47, 781–788. [Google Scholar] [CrossRef]
- Gresele, P.; Momi, S.; Falcinelli, E. Anti-platelet therapy: phosphodiesterase inhibitors. Br. J. Clin. Pharmacol. 2011, 72, 634–646. [Google Scholar] [CrossRef]
- Janitschke, D.; Lauer, A.A.; Bachmann, C.M.; Grimm, H.S.; Hartmann, T.; Grimm, M.O.W. Methylxanthines and Neurodegenerative Diseases: An Update. Nutrients 2021, 13, 803. [Google Scholar] [CrossRef]
- Oizumi, K.; Baumann, P.; Siira, P.; Vanharanta, H.; Myllylä, V.; Chiu, M.-J.; Chen, R.-C.; Tseng, C.-Y.; Rossi, A.; Iidaka, T.; et al. European Pentoxifylline Multi-Infarct Dementia Study. Eur. Neurol. 1996, 36, 315–321. [Google Scholar] [CrossRef]
- Treves, T.; Korczyn, A. Denbufylline in Dementia: A Double-Blind Controlled Study. Dement. Geriatr. Cogn. Disord. 1999, 10, 505–510. [Google Scholar] [CrossRef]
- Bondari, S.; Bondari, D.; Pîrşcoveanu, M.; Moroşanu, D.V.; Muşetescu, A.E.; Tudorică, V.; Pîrşcoveanu, D.F.V. Study on cognitive decline in patients diagnosed with brain tumors. Rom J Morphol Embryol. 2017, 58, 1185–1192. [Google Scholar]
- Freitas, S.; Simões, M.R.; Marôco, J.; Alves, L.; Santana, I. Construct Validity of the Montreal Cognitive Assessment (MoCA). J. Int. Neuropsychol. Soc. 2011, 18, 242–250. [Google Scholar] [CrossRef]
- Nasreddine, Z.S.; Phillips, N.A.; Bédirian, V.; Charbonneau, S.; Whitehead, V.; Collin, I.; Cummings, J.L.; Chertkow, H. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment. J. Am. Geriatr. Soc. 2005, 53, 695–699. [Google Scholar] [CrossRef]
- Anca, P.S.; Toth, P.P.; Kempler, P.; Rizzo, M. Gender differences in the battle against COVID-19: Impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomes. Int. J. Clin. Pr. 2020, 75, e13666. [Google Scholar] [CrossRef]
- Pantoni, L.; Carosi, M.; Amigoni, S.; Mascalchi, M.; Inzitari, D. A Preliminary Open Trial with Nimodipine in Patients with Cognitive Impairment and Leukoaraiosis. Clin. Neuropharmacol. 1996, 19, 497–506. [Google Scholar] [CrossRef]
- Ensayo clínico experimental, doblemente ciego, aleatorizado, controlado con placebo, del efecto de nicardipino en la función cognitiva en pacientes afectos de demencia vascular. Grupo Español de Estudio de Nicardipino en Demencia Vascular. Rev Neurol. 1999, 28, 835–845. [CrossRef]
- Weyer, G.; Eul, A.; Milde, K.; Wierich, W.; Herrmann, W.M. Cyclandelate in the Treatment of Patients with Mild to Moderate Primary Degenerative Dementia of the Alzheimer Type or Vascular Dementia: Experience from a Placebo Controlled Multi-center Study. Pharmacopsychiatry 2000, 33, 89–97. [Google Scholar] [CrossRef]
- Winblad, B.; Poritis, N. Memantine in severe dementia: results of the9M-best study (benefit and efficacy in severly demented patients during treatment with memantine). Int. J. Geriatr. Psychiatry 1999, 14, 135–146. [Google Scholar] [CrossRef]
- Oken, B.S.; Storzbach, D.M.; Kaye, J.A. The Efficacy of Ginkgo biloba on Cognitive Function in Alzheimer Disease. Arch. Neurol. 1998, 55, 1409–1415. [Google Scholar] [CrossRef]
- Kobus-Cisowska, J.; Flaczyk, E.; Rudzińska, M.; Kmiecik, D. Antioxidant properties of extracts from Ginkgo biloba leaves in meatballs. Meat Sci. 2014, 97, 174–180. [Google Scholar] [CrossRef] [PubMed]
- Franke, A.G.; Heinrich, I.; Lieb, K.; Fellgiebel, A. The use of Ginkgo biloba in healthy elderly. AGE 2013, 36, 435–444. [Google Scholar] [CrossRef] [PubMed]
- Saldmann, F.; Funel, A.; Jacquet, P. Efficacy of naftidrofuryl in patients with moderate senile dementia. Curr. Med Res. Opin. 1991, 12, 379–389. [Google Scholar] [CrossRef]
- Emeriau, J.-P.; Lehert, P.; Mosnier, M. Efficacy of naftidrofuryl in patients with vascular or mixed dementia: Results of a multicenter, double-blind trial. Clin. Ther. 2000, 22, 834–844. [Google Scholar] [CrossRef]
- Román, G.C.; Kalaria, R.N. Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiol. Aging 2005, 27, 1769–1785. [Google Scholar] [CrossRef]
- Jia, J.P.; Jia, J.M.; Zhou, W.D.; et al. Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia. Chin Med J (Engl) 2004, 117, 1161–1164. [Google Scholar]
- Rakonczay, Z.; Horváth, Z.; Juhász, A.; Kálmán, J. Peripheral cholinergic disturbances in Alzheimer's disease. Chem. Interactions 2005, 157-158, 233–238. [Google Scholar] [CrossRef]
- Yamamoto, Y.; Nakanot, S.; Kawashima, S.; Nakamura, S.; Urakami, K.; Kato, T.; Kameyam, M. Plasma and Serum G4 Isoenzyme of Acetylcholinesterase in Patients with Alzheimer-Type Dementia and Vascular Dementia. Ann. Clin. Biochem. Int. J. Biochem. Lab. Med. 1990, 27, 321–326. [Google Scholar] [CrossRef]
- Kurz, A.; Farlow, M.; Quarg, P.; Spiegel, R. Disease Stage in Alzheimer Disease and Treatment Effects of Rivastigmine. Alzheimer Dis. Assoc. Disord. 2004, 18, 123–128. [Google Scholar] [CrossRef]
© 2024 by the authors. 2024 Denisa Floriana Vasilica Pîrșcoveanu, Carmen Valeria Albu, Elena Anca Târtea, Iulia Cristina Mărginean, George Alexandru Iacob, Elena Pinoșanu, Anca Maria Țucă, Cristina Maria Mărginean, Raluca Elena Sandu, Mircea Pîrșcoveanu.
Share and Cite
Pîrșcoveanu, D.F.V.; Albu, C.V.; Târtea, E.A.; Mărginean, I.C.; Iacob, G.A.; Pinoșanu, E.; Țucă, A.M.; Mărginean, C.M.; Sandu, R.E.; Pîrșcoveanu, M. Updating Data on Cognitive Impairment in Stroke Patients. J. Mind Med. Sci. 2024, 11, 49-61. https://doi.org/10.22543/2392-7674.1456
Pîrșcoveanu DFV, Albu CV, Târtea EA, Mărginean IC, Iacob GA, Pinoșanu E, Țucă AM, Mărginean CM, Sandu RE, Pîrșcoveanu M. Updating Data on Cognitive Impairment in Stroke Patients. Journal of Mind and Medical Sciences. 2024; 11(1):49-61. https://doi.org/10.22543/2392-7674.1456
Chicago/Turabian StylePîrșcoveanu, Denisa Floriana Vasilica, Carmen Valeria Albu, Elena Anca Târtea, Iulia Cristina Mărginean, George Alexandru Iacob, Elena Pinoșanu, Anca Maria Țucă, Cristina Maria Mărginean, Raluca Elena Sandu, and Mircea Pîrșcoveanu. 2024. "Updating Data on Cognitive Impairment in Stroke Patients" Journal of Mind and Medical Sciences 11, no. 1: 49-61. https://doi.org/10.22543/2392-7674.1456
APA StylePîrșcoveanu, D. F. V., Albu, C. V., Târtea, E. A., Mărginean, I. C., Iacob, G. A., Pinoșanu, E., Țucă, A. M., Mărginean, C. M., Sandu, R. E., & Pîrșcoveanu, M. (2024). Updating Data on Cognitive Impairment in Stroke Patients. Journal of Mind and Medical Sciences, 11(1), 49-61. https://doi.org/10.22543/2392-7674.1456